Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ANAB
#1815
AnaptysBio, Inc. Common Stock
55.050
0
+1.79%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+1.79%
Aylık değişim
+11.53%
6 aylık değişim
+56.39%
Yıllık değişim
+56.39%
Önceki kapanış
54.080
0
Open
55.050
0
Bid
Ask
Low
55.050
0
High
55.146
0
Hacim
74
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ANAB
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
27.37 M
27.67 M
27.93 M
26.76 M
30.67 M
—
Valuation ratios
Enterprise value
337.92 M
465.89 M
744.84 M
544.79 M
282.95 M
2.05 B
Price to earnings ratio
—
-16.47
-6.39
-3.57
-2.59
-22.76
Price to sales ratio
—
15.09
80
34.05
4.12
19.36
Price to cash flow ratio
—
-20.76
-11.18
-4.84
-2.78
-18.76
Price to book ratio
—
2.67
3.14
6.63
5.3
40.34
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.05
0.09
0.21
0.36
0.3
0.3
Return on equity %
0.05
0.16
0.49
1.86
2.05
2.84
Return on invested capital %
238.66
409.35
360.61
619.98
899.03
708.52
Gross margin %
100
100
100
100
100
400
Operating margin %
31.84
89.93
1 119.41
958.27
125.93
284.62
EBITDA margin %
—
—
—
—
—
—
Net margin %
26.57
91.49
1 251.33
953.66
159.1
385.47
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
20.01
34.4
17.16
10.87
9.51
34.65
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.18
0.12
0.02
0.03
0.19
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
1.67
2.61
4.49
4.77
5.04
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
19.98
15.67
14.52
13.58
42.47
Net current asset value per share
—
20.19
15.88
15.11
15.22
48.59
Tangible book value per share
—
12.99
9.31
3.27
2.5
6.17
Working capital per share
—
19.6
14.95
13.72
13.62
43.01
Book value per share
—
12.99
9.31
3.27
2.5
6.17
Haberler
FDA, Vanda’nın nadir cilt hastalığı başvurusunu kabul etti
FDA accepts Vanda’s imsidolimab application for rare skin disorder
AnaptysBio hissesi 57,73 dolarla 52 haftalık zirve yaptı
AnaptysBio stock hits 52-week high at $57.73
These IBD 50 Stocks Form Secondary Buy Areas, But Watch These Risks
AnaptysBio hisseleri 52,56 dolar ile 52 haftalık zirveye ulaştı
AnaptysBio stock hits 52-week high at $52.56
Biotech Leader Eyes Spinoff Amid Massive Sales Surge
AnaptysBio, Inc. (ANAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AnaptysBio hissesi: UBS, devam eden GSK davasına rağmen Al tavsiyesini yineledi
AnaptysBio stock: UBS reiterates Buy rating amid ongoing GSK litigation
Royalty Pharma ve Teva’nın 500 milyon dolarlık IL-15 anlaşması AnaptysBio hisselerini yükseltti